(19)
(11) EP 3 644 970 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
16.03.2022 Bulletin 2022/11

(45) Mention of the grant of the patent:
09.02.2022 Bulletin 2022/06

(21) Application number: 18737225.5

(22) Date of filing: 29.06.2018
(51) International Patent Classification (IPC): 
A61K 9/16(2006.01)
A61P 35/00(2006.01)
 A61K 31/18(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/1635; A61K 9/1652; A61K 9/2059; A61K 9/4858; A61K 9/4866; A61K 31/18; A61P 35/00
(86) International application number:
PCT/EP2018/067717
(87) International publication number:
WO 2019/002614 (03.01.2019 Gazette 2019/01)

(54)

NEW ORAL FORMULATIONS OF BELINOSTAT

NEUE ORALE FORMULIERUNGEN VON BELINOSTAT

NOUVELLES FORMULATIONS ORALES DE BELINOSTAT

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 30.06.2017 US 201762527684 P
03.07.2017 EP 17305853

(43) Date of publication of application:
06.05.2020 Bulletin 2020/19

(73) Proprietor: ACROTECH BIOPHARMA LLC
East Windsor, NJ 08520 (US)

(72) Inventors:
  • PIVETTE, Perrine
    94140 Alfortville (FR)
  • LEMARCHAND, Caroline
    75014 Paris (FR)
  • YATES, Ian
    Bend Oregon 97701 (US)
  • BLOOM, Corey
    Bend Oregon 97701 (US)

(74) Representative: Lavoix 
2, place d'Estienne d'Orves
75441 Paris Cedex 09
75441 Paris Cedex 09 (FR)


(56) References cited: : 
WO-A1-2011/064663
AU-B2- 2012 213 940
US-A1- 2014 148 449
 WO-A1-2014/049549
US-A1- 2008 317 851
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).